283.88
전일 마감가:
$280.00
열려 있는:
$280.48
하루 거래량:
716.64K
Relative Volume:
1.10
시가총액:
$23.28B
수익:
$14.14B
순이익/손실:
$942.70M
주가수익비율:
25.15
EPS:
11.2856
순현금흐름:
$1.38B
1주 성능:
+7.05%
1개월 성능:
+10.52%
6개월 성능:
+13.15%
1년 성능:
+7.42%
래버러토리 코퍼레이션 Stock (LH) Company Profile
명칭
Labcorp Holdings Inc
전화
(336) 229-1127
주소
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
LH
Labcorp Holdings Inc
|
283.88 | 22.96B | 14.14B | 942.70M | 1.38B | 11.29 |
|
TMO
Thermo Fisher Scientific Inc
|
513.33 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
193.72 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
537.58 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
|
NTRA
Natera Inc
|
276.27 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
133.39 | 37.52B | 7.23B | 1.41B | 1.09B | 4.979 |
래버러토리 코퍼레이션 Stock (LH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-01-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-30 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-10-01 | 개시 | Piper Sandler | Neutral |
| 2024-03-25 | 업그레이드 | Argus | Hold → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-09 | 개시 | Evercore ISI | In-line |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-19 | 다운그레이드 | Argus | Buy → Hold |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-01-11 | 업그레이드 | Argus | Hold → Buy |
| 2021-01-11 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 재개 | Deutsche Bank | Buy |
| 2020-05-15 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-04-29 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2019-07-16 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-01-17 | 개시 | UBS | Buy |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-30 | 다운그레이드 | Argus | Buy → Hold |
| 2018-10-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | 재개 | BofA/Merrill | Buy |
| 2018-06-07 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | 개시 | Argus | Buy |
모두보기
래버러토리 코퍼레이션 주식(LH)의 최신 뉴스
Form 144 LABCORP HOLDINGS INC. For: 1 July By Investing.com - Investing.com South Africa
LH (LH) Form 144: insider sale notice for 7,138 shares - Stock Titan
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 - BioSpace
Labcorp Holdings Inc. (LH) Announces Upcoming Release of Q2 2026 Financial Results - GuruFocus
Labcorp to report Q2 2026 results July 30; webcast at 9:00 a.m. ET - TradingView
Labcorp (NYSE: LH) sets July 30, 2026 Q2 earnings webcast - Stock Titan
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp extends ColoSense rollout, shares trade steadily on Xetra - Ad-hoc-news.de
Price to earnings forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Price to earnings forward of Labcorp Holdings Inc. – SWB:N6B - TradingView
Enterprise value to revenue forward of Labcorp Holdings Inc. – SWB:N6B - TradingView
Price to earnings forward of Labcorp Holdings Inc. – BIVA:LH - TradingView
Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test - Yahoo Finance
Price to sales forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Price to sales forward of Labcorp Holdings Inc. – BOATS:LH - TradingView
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is Labcorp Holdings stock underperforming the Nasdaq? - MSN
Enterprise value to EBITDA forward of Labcorp Holdings Inc. – BOATS:LH - TradingView
Enterprise value to revenue forward of Labcorp Holdings Inc. – BOATS:LH - TradingView
Labcorp Holdings (LH) Could Be 14% Undervalued As Growth Narrative Builds - Sahm
Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh - TradingView
Price to earnings forward of Labcorp Holdings Inc. – BOATS:LH - TradingView
Enterprise value to EBIT forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Enterprise value to revenue forward of Labcorp Holdings Inc. – LSX:A40C39 - TradingView
Price to book forward of Labcorp Holdings Inc. – LSX:A40C39 - TradingView
Enterprise value to EBIT forward of Labcorp Holdings Inc. – LSX:A40C39 - TradingView
Labcorp Holdings Inc. Actuals & Estimates (NYSE:LH) - TradingView
LH Forecast — Price Target — Prediction for 2027 - TradingView
Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks - Yahoo Finance
Is it the Right Time to Add Labcorp Stock to Your Portfolio? - Yahoo Finance
Labcorp Holdings Inc (LH) Institutional Confidence - TradingKey
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Husch Blackwell Assists LabCorp in Securing Texas Supreme Court Victory in Medicaid Fraud Statute Case - Husch Blackwell
Labcorp Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test - Sahm
Labcorp Announces Nationwide Availability of ColoSense®, the Fir - GuruFocus
Labcorp (LH) Launches ColoSense, an Innovative Colorectal Cancer Screening Test - GuruFocus
Labcorp launches FDA-approved at-home colorectal cancer test By Investing.com - Investing.com Canada
Labcorp brings at-home colorectal cancer test to all 50 states - Stock Titan
LHLabcorp Holdings Inc Options - Finviz
Labcorp Holdings Inc (LH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
$35M Labcorp data breach class action settlement - Class Action Lawsuits
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is Labcorp Holdings Stock Underperforming the Nasdaq? - Yahoo Finance
Labcorp Holdings Inc (LH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Labcorp Holdings Inc (LH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Labcorp Holdings Inc (LH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Labcorp Holdings Inc (LH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Labcorp Holdings Inc (LH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Labcorp Holdings Inc (LH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Labcorp Holdings Inc (LH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
래버러토리 코퍼레이션 (LH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):